Pure Global

Metabolic Response to Food in Advanced Lung Cancer - Trial NCT05937074

Access comprehensive clinical trial information for NCT05937074 through Pure Global AI's free database. This phase not specified trial is sponsored by Pennington Biomedical Research Center and is currently Recruiting. The study focuses on Carcinoma, Non-Small-Cell Lung. Target enrollment is 12 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05937074
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT05937074
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Metabolic Response to Food in Advanced Lung Cancer

Study Focus

Weight loss (%)

Observational

other

Sponsor & Location

Pennington Biomedical Research Center

Baton Rouge, United States of America

Timeline & Enrollment

N/A

Jul 18, 2023

Jun 30, 2025

12 participants

Primary Outcome

Respiratory quotient

Summary

This goal of this study is to describe how unintentional weight loss influences fasting and
 post-prandial metabolic flexibility in participants with advanced non-small cell lung cancer.

ICD-10 Classifications

Carcinoma in situ: Bronchus and lung
Secondary malignant neoplasm of lung
Malignant neoplasm: Lower lobe, bronchus or lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm of bronchus and lung

Data Source

ClinicalTrials.gov

NCT05937074

Non-Device Trial